Dr. Kirk R. Schultz is a pediatric oncologist who has dedicated is career to improving health outcomes for children and adolescents with cancer. Through his research, he has made landmark breakthroughs in pediatric leukemia and the prevention of graft versus host disease, a life-threatening complication of blood an marrow transplantation. He is an international leader whose contributions include translational immunology and biomarker research, multicentre clinical trials, and leadership in practice and policy related to blood and bone marrow transplantation. Dr. Schultz is a tireless advocate for the inclusion of pediatrics in cance trials, research networks and policy/practice consensus groups.